8-K Announcements
6Material company update
May 27, 2026·SEC
Material company update
Apr 10, 2026·SEC
Material company update
Mar 31, 2026·SEC
Callan JMB Inc. (CJMB)Earnings, Financials & Key Ratios
CJMB•NASDAQ
$0.76
Price updated Jun 27, 2026
SectorIndustrialsIndustryFreight & LogisticsSub-IndustryContract Logistics and Specialized Warehousing
AboutCallan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.Show more
- Revenue$6M-12.8%
- EBITDA-$6M-197.5%
- Net Income-$8M-247.3%
- EPS (Diluted)-1.82-109.2%
- Gross Margin36.77%-5.8%
- EBITDA Margin-110.79%-241.2%
- Operating Margin-113.44%-227.3%
- Net Margin-139.19%-298.3%
- ROE-289.61%-655.6%
CJMB Price & Volume
Callan JMB Inc. (CJMB) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Contraction Threatens Operational Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity exhaustion and dilution
Key Thesis Takeaways
- Callan JMB Inc.
- faces a critical inflection point as sustained revenue contraction and negative operating leverage continue to erode the company's financial foundation.
- The firm's inability to scale SG&A expenses, which remain stubbornly high relative to the $1.1M revenue reported in 2026Q1, suggests a structural failure in its current business model.
- Investors should remain cautious as the rapid depletion of cash reserves and rising debt-to-equity ratio of 1.40 indicate significant liquidity risks that may necessitate dilutive financing.
Verdict Logic
the company's inability to generate positive free cash flow, coupled with a -155.1% FCF margin in 2026Q1, suggests an unsustainable path that poses a high risk of capital impairment.
CJMB Growth Metrics
Callan JMB Inc. (CJMB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-36.89%
TTM-13.54%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-187.6%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-76.33%
Return on Capital
10 Years-32.79%
5 Years-32.79%
3 Years-58.56%
Last Year-159.05%
CJMB Recent Earnings
Callan JMB Inc. (CJMB) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.59
—
Rev
—
—
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.56
—
Rev
$1M
—
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.61
—
Rev
$1M
—
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$0.31
—
Rev
$2M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.59 | — |
| Q2 2026 | Mar 31, 2026 | $0.56 | $1M |
| Q4 2025 | Nov 14, 2025 | $0.61 | $1M |
| Q3 2025 | Aug 14, 2025 | $0.31 | $2M |
Based on last 5 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Callan JMB Inc. (CJMB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.76 | $3.33M | -0.42 | -12.8% | -139.19% | -289.61% | — | |
| $40.12 | $3.95B | 18.49 | 3.25% | 8.48% | 29.43% | — | |
| $138.55 | $9.57B | 22.27 | 9.55% | 16.26% | 18.57% | — | |
| $64.48 | $4.8B | 21.93 | 26.98% | 14.46% | 35.15% | — | |
| $151.63 | $3.67B | 22.70 | 14.77% | 10.32% | 20.08% | — | |
| $341.69 | $13.22B | 24.32 | 29.49% | 16.3% | 35.52% | — |
Compare CJMB vs Peers
Callan JMB Inc. (CJMB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CJMB SEC Filings & Documents
Callan JMB Inc. (CJMB) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when CJMB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CJMB Frequently Asked Questions
Callan JMB Inc. (CJMB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Callan JMB Inc. 's revenue?
Callan JMB Inc. (CJMB) reported $5.4M in revenue for fiscal year 2025. This represents a 76% decrease from $22.8M in 2022.
How fast is Callan JMB Inc. growing?
Callan JMB Inc. (CJMB) saw revenue decline by 12.8% over the past year.
Is CJMB profitable?
Callan JMB Inc. (CJMB) reported a net loss of $9.9M for fiscal year 2025.
Dividend & Returns
What is CJMB's return on equity?
Callan JMB Inc. (CJMB) has a return on equity (ROE) of -289.6%. Negative ROE indicates the company is unprofitable.
What is Callan JMB Inc. 's free cash flow?
Callan JMB Inc. (CJMB) had negative free cash flow of $4.7M in fiscal year 2025, likely due to heavy capital investments.